Primary links
- Introduction
- Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists
- American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
- Introduction
- Methods
- Diagnosis: Histopathology and Differential Diagnosis
- Initial Evaluations
- Establishing Treatment Goals
- Approaches to Locoregional Disease
- Approaches to Advanced Metastatic Disease (Stage IVC)
- Palliative Care and Hospice
- Surveillance and Long-Term Monitoring
- Summary
- Acknowledgments
- Author Disclosure Statement
- References
- American Thyroid Association Design and Feasibility of a Prospective Randomized Controlled Trial of Prophylactic Central Lymph
- American Thyroid Association Statement on the Essential Elements of Interdisciplinary Communication of Perioperative Information
- Introduction
- Methods
- Results
- Conclusions
- Author Disclosure Statement
- References
- Appendix A. Sample Narrative Operative Report for Total Thyroidectomy
- Appendix B: Essential Data Fields for Synoptic Reporting on Patients with Thyroid Cancer
- Appendix C: Electronic Template for Day-of-Thyroidectomy Letter to Referring Provider(s)
- Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpart
- Hyperthyroidism and Other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Assoc
- Introduction
- Methods of Development of Evidence-Based Guidelines
- Results
- [B] How should clinically or incidentally discovered thyrotoxicosis be evaluated and initially managed?
- [C] How should overt hyperthyroidism due to GD be managed?
- [D] If 131I therapy is chosen, how should it be accomplished?
- [E] If antithyroid drugs are chosen as initial management of GD, how should the therapy be managed?
- [F] If thyroidectomy is chosen for treatment of GD, how should it be accomplished?
- [G] How should thyroid nodules be managed in patients with GD?
- [H] How should thyroid storm be managed?
- [I] How should overt hyperthyroidism due to TMNG or TA be managed?
- [J] If 131I therapy is chosen, how should it be accomplished?
- [K] If surgery is chosen, how should it be accomplished?
- [L] Is there a role for antithyroid drug therapy in patients with TMNG or TA?
- [M] Is there a role for radiofrequency, thermal, or alcohol ablation in the management of TA or TMNG?
- [N] How should GD be managed in children and adolescents?
- [O] If antithyroid drugs are chosen as initial management of GD in children, how should the therapy be managed?
- [P] If radioactive iodine is chosen as treatment for GD in children, how should it be accomplished?
- [Q] If thyroidectomy is chosen as treatment for GD in children, how should it be accomplished?
- [R] How should SH be managed?
- [S] How should hyperthyroidism in pregnancy be managed?
- [T] How should hyperthyroidism be managed in patients with Graves' ophthalmopathy?
- [U] How should overt drug-induced thyrotoxicosis be managed?
- [V] How should thyrotoxicosis due to destructive thyroiditis be managed?
- [W] How should thyrotoxicosis due to unusual causes be managed?
- Acknowledgments
- Disclosure Statement
- Appendix A
- References
- Radiation Safety in the Treatment of Patients with Thyroid Diseases by Radioiodine 131I: Practice Recommendations of the America
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
- Official Italian Translation of the 2009 American Thyroid Association Management Guidelines for Patients with Thyroid Nodules an
- Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
- Consensus Statement on the Terminology and Classification of Central Neck Dissection for Thyroid Cancer